Menu
Back to User profile » Professor Alexander Turpie
Papers published by Professor Alexander Turpie:
Rivaroxaban for venous thromboembolism prevention after major orthopedic surgery: translating trial data into routine clinical practice
Beyer-Westendorf J, Mouret P, Turpie AGG
Orthopedic Research and Reviews 2017, 9:1-11
Published Date: 31 January 2017
The effects of timing of prophylaxis, type of anesthesia, and use of mechanical methods on outcome in major orthopedic surgery - subgroup analyses from 17,701 patients in the XAMOS study
Haas S, Holberg G, Kreutz R, Lassen MR, Mantovani L, Haupt V, Vogtländer K, Turpie AGG
Vascular Health and Risk Management 2016, 12:209-218
Published Date: 18 May 2016
XANTUS: rationale and design of a noninterventional study of rivaroxaban for the prevention of stroke in patients with atrial fibrillation
Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Eickels MV, Turpie AGG
Vascular Health and Risk Management 2014, 10:425-434
Published Date: 17 July 2014
Benefit–risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty
Levitan B, Yuan Z, Turpie AGG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM
Vascular Health and Risk Management 2014, 10:157-167
Published Date: 26 March 2014
Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
Turpie AGG
Therapeutics and Clinical Risk Management 2014, 10:197-205
Published Date: 22 March 2014
Practical guidance for using rivaroxaban in patients with atrial fibrillation: balancing benefit and risk
Haas S, Bode C, Norrving B, Turpie AGG
Vascular Health and Risk Management 2014, 10:101-114
Published Date: 10 March 2014
Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery
Turpie AG, Schmidt AC, Kreutz R, Lassen MR, Jamal W, Mantovani L, Haas S
Vascular Health and Risk Management 2012, 8:363-370
Published Date: 1 June 2012